Literature DB >> 24862392

Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption.

Andreas Becker1, Praful Ravi2, Florian Roghmann3, Quoc-Dien Trinh4, Zhe Tian3, Alexandre Larouche3, Simon Kim5, Shahrokh F Shariat6, Luis Kluth7, Roland Dahlem7, Margit Fisch7, Markus Graefen8, Christian Eichelberg3, Pierre I Karakiewicz3, Maxine Sun3.   

Abstract

OBJECTIVE: To assess postoperative complication profiles and 30-day mortality (30 dM) in older patients undergoing either laparoscopic radical nephrectomy (LRN) compared with open partial nephrectomy (OPN) or laparoscopic partial nephrectomy (LPN) for early stage renal cell carcinoma.
METHODS: Using the Surveillance, Epidemiology, and End Results-Medicare linked database, 2277 patients aged>65 years with T1 renal cell carcinoma, who underwent LRN, OPN, or LPN were identified (1992-2005). Surgical and medical complications and 30 dM after nephrectomy were abstracted. Bivariate and multivariate logistic regression analyses were performed.
RESULTS: Relative to LRN, the rate of surgical complications was higher for OPN (28% vs 20%; P<.001) and LPN (29% vs 20%; P=.01). These differences persisted after multivariate adjustment for patient and tumor characteristics (OPN: odds ratio, 1.6; 95% confidence interval, 1.28-1.91; P<.001; LPN: odds ratio, 1.6; 95% confidence interval, 1.13-2.39; P=.01). Specifically, relative to LRN, OPN was associated with a 7% higher rate of genitourinary complications (13% vs 20%; P<.001). Similarly, relative to LRN, LPN was associated with a 7% higher rate of genitourinary complications (13% vs 20%; P=.001) and with a 4% higher rate of hemorrhagic complications (8% vs 4%; P=.02). No statistically significant differences were recorded for all other surgical and/or medical complication types and 30 dM (all P≥.2).
CONCLUSION: The complication and 30-dM rates were not different between LRN, OPN, and LPN groups. Exceptions include genitourinary complications that favor LRN relative to OPN and LPN and hemorrhagic complications that favor LRN relative to LPN. It is doubtful that these results should discourage the use of partial nephrectomy relative to LRN in older patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24862392     DOI: 10.1016/j.urology.2014.01.050

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Preoperative Frailty Is Associated With Discharge to Skilled or Assisted Living Facilities After Urologic Procedures of Varying Complexity.

Authors:  Anne M Suskind; Chengshi Jin; Matthew R Cooperberg; Emily Finlayson; W John Boscardin; Saunak Sen; Louise C Walter
Journal:  Urology       Date:  2016-07-05       Impact factor: 2.649

Review 2.  Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.

Authors:  Hiten D Patel; Phillip M Pierorazio; Michael H Johnson; Ritu Sharma; Emmanuel Iyoha; Mohamad E Allaf; Eric B Bass; Stephen M Sozio
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-08       Impact factor: 8.237

3.  Surgical management of stage T1 renal tumours at Canadian academic centres.

Authors:  Luke T Lavallée; Simon Tanguay; Michael A Jewett; Lori Wood; Anil Kapoor; Ricardo A Rendon; Ronald B Moore; Louis Lacombe; Jun Kawakami; Stephen E Pautler; Darrel E Drachenberg; Peter C Black; Jean-Baptiste Lattouf; Christopher Morash; Ilias Cagiannos; Zhihui Liu; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

4.  Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database.

Authors:  Brian J Jordan; Richard S Matulewicz; Brian Trihn; Shilajit Kundu
Journal:  World J Urol       Date:  2017-05-17       Impact factor: 4.226

Review 5.  Comorbidity and frailty assessment in renal cell carcinoma patients.

Authors:  Jean Courcier; Alexandre De La Taille; Nathalie Lassau; Alexandre Ingels
Journal:  World J Urol       Date:  2021-02-22       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.